Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 6Thoracic 3Gastrointestinal 3Genitourinary 2Breast 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Brain Neoplasms 7Breast Neoplasms 5Testicular Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neuroblastoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Hairy Cell 4Hodgkin Disease 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Blast Crisis 4Primary Myelofibrosis 3Neoplasms 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Glioma 3Wilms Tumor 2Teratoma, Testicular 2Teratoma 2Sezary Syndrome 2Seminoma 2

Interventions

Radiosurgery 22Nivolumab 21Ipilimumab 19pembrolizumab 15Temozolomide 11dabrafenib 10binimetinib 10encorafenib 8Cyclophosphamide 8trametinib 7Magnetic Resonance Spectroscopy 7Bevacizumab 6fludarabine 5cobimetinib 5Specimen Handling 5CTLA-4 Antigen 5fludarabine phosphate 3aldesleukin 3Vemurafenib 3Thalidomide 3Paclitaxel 3Oxaliplatin 3Interleukin-2 3Gemcitabine 3Drug Therapy 3Carboplatin 3130-nm albumin-bound paclitaxel 3ulixertinib 2tovorafenib 2relatlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Therapeutics × CNS × Clear all
NCT06180460 2025-10-08

CALM: Managing Distress in Malignant Brain Cancer

Virginia Commonwealth University

Phase NA Completed
60 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡